Company intelligence / Profile preview

Stemexcel

Vancouver, British Columbia, Canadastemexcel.org ↗

Ownership: Private
Employees: ~2000
Development stage: Other

Overview

STEMCELL Technologies is a leading Canadian biotechnology company providing over 2,500 specialized reagents, tools, instruments, and services to support life science research globally. Its offerings enable advances in stem cell biology, immunology, cancer research, regenerative medicine, and cellular therapies. Recent acquisitions have expanded its capabilities into enabling clinical applications of cell therapies.

Modalities: Cell therapyInduced pluripotent stem cell derived therapyStem cell therapy
Industry: Non-Drug Biotech

Partnerships

Massachusetts Institute of Technology

Beyond the preview

Go deeper on Stemexcel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stemexcel.

Explore the full profile